Provention Bio Inc PRVB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/22 EDT
4.28quote price arrow up+0.03 (+0.71%)
Volume
703,011
Close
4.25quote price arrow up+0.20 (+4.94%)
Volume
1,334,641
52 week range
3.40 - 9.70
Loading...
  • Open4.11
  • Day High4.25
  • Day Low3.97
  • Prev Close4.25
  • 52 Week High9.70
  • 52 Week High Date06/28/21
  • 52 Week Low3.40
  • 52 Week Low Date01/27/22

Key Stats

  • Market Cap272.17M
  • Shares Out64.04M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta2.62
  • YTD % Change-24.38

KEY STATS

  • Open4.11
  • Day High4.25
  • Day Low3.97
  • Prev Close4.25
  • 52 Week High9.70
  • 52 Week High Date06/28/21
  • 52 Week Low3.40
  • 52 Week Low Date01/27/22
  • Market Cap272.17M
  • Shares Out64.04M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta2.62
  • YTD % Change-24.38

RATIOS/PROFITABILITY

  • EPS (TTM)-1.64
  • P/E (TTM)-2.59
  • Fwd P/E (NTM)-1.79
  • EBITDA (TTM)-111.727M
  • ROE (TTM)-74.77%
  • Revenue (TTM)1.98M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,263.80%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Provention Bio Inc

There is no recent news for this security.

Profile

MORE
Provention Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on intercepting and preventing immune-mediated diseases. The Company's product pipeline includes PRV-031 (teplizumab), PRV-3279, PRV-015 (ordesekimab) and PRV-101. Teplizumab is a humanized, anti-CD3 monoclonal antibody (mAb) for the delay of clinical type 1 diabetes (T1D) in at-risk individuals and for patients with newly diagnosed T1D. PRV-3279 is a humanized bispecific scaffold molecule...
Wayne Pisano
Independent Chairman of the Board
Ashleigh Palmer
President, Chief Executive Officer, Co-Founder, Director
Christina Yi
Chief Operations Officer
Thierry Chauche
Chief Financial Officer
Address
55 BROAD STREET, 2ND FLOOR
Red Bank, NJ
07701
United States

Top Peers

SYMBOLLASTCHG%CHG
ACIU
AC Immune SA
3.23-0.01-0.31%
ALVR
Allovir Inc
4.27-0.24-5.32%
OMIC
Singular Genomics Systems Inc
3.76+0.13+3.58%
PRLD
Prelude Therapeutics Inc
5.46+0.17+3.21%
RLYB
Rallybio Corp
8.00+0.64+8.70%